新闻
2024-07-05
上市批准并购
2024-07-05
IntelGenx Obtains Preliminary Efficacy Results for the ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease
上市批准
2024-07-04
创新FGFR2抑制剂获FDA快速通道资格,治疗这种癌症
快速通道免疫疗法抗体药物偶联物
2024-07-04
疫苗引进/卖出信使RNA
2024-07-04
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination
上市批准快速通道临床结果
2024-07-04
Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
临床结果生物类似药
2024-07-04
Inozyme Pharma Announces FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency
快速通道临床研究临床结果
2024-07-04
基因疗法临床结果引进/卖出
2024-07-04
超70%患者达主要终点!潜在“first-in-class"CAR-T疗法积极临床结果公布
细胞疗法信使RNA免疫疗法临床结果
2024-07-04
治疗精神分裂症,小分子变构剂新药获批临床
申请上市临床申请
更多数据请注册后访问新药情报库PC端查看
synapse.zhihuiya.com
复制网址